Lec 5: End of Life Care Flashcards

1
Q

LO: Palliative care vs Hospice

A

-Palliative care – specialized medical care for people with serious illness that focuses on providing relief from the pain, symptoms and distress of serious illness
- Hospice - type of care and a philosophy of care that focuses on the palliation of a terminally ill patient’s symptoms (Terminal illness – estimated survival 6 months or less)
.
-ALL hospice care is palliative but NOT all palliative care is hospice. BOTH are team-based approaches with focus on improving quality of life including spiritual and psychosocial support

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

LO: Palliative Care: Unlike hospice, palliative care can be provided________________________?
Talk about Supportive Care

A

-Unlike hospice, palliative care can be provided at the same time as curative treatments
- Appropriate at any age and at any stage of serious illness
.
- Supportive care – extra layer of support
—- Time devoted to intensive family meetings and patient/family counseling
—- Resolves questions and conflicts between families/patients and physicians on achievable goals of care
—- Provides expertise in pain and symptom management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Palliative Care/ End of Life Care/ and Last Hours Care

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Palliative Care and Oncology
A Study by Temel et al – NEJM 2010;363:733-42…Talk about it

A
  • 151 patients with newly-diagnosed metastatic NSCLC randomized to standard treatment or standard treatment + PC
  • Primary Outcome: QOL
  • Secondary outcomes: mood, aggressive treatment at EOL
    .
    The results?
    Results in intervention arm (Standard tx + PC)
    -Better understanding of the disease, prognosis, and options
    -Significantly higher QOL scores (p=0.03)
    -Fewer depressive symptoms (p=0.01)
    -Less aggressive end of life care (p=0.05)
    -Less use of chemotherapy near end of life
    -Less hospitalization and intubation
    -More and longer use of hospice
    -Survival 2.7 months longer (p=0.02)
    NOTE: just know that overall standard care + PC in combo is better!! Increase patient’s survival ! PC combo also decrease admission/readmission and cost!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Medicare Hospice Benefit (Passed by Congress in 1982): Criteria for enrollment and certification period?

A

4 criteria for enrollment
- Eligibility for Medicare Part A (hospital insurance)
- Medicare approved hospice program
- Signed statement by patient choosing hospice care instead of “regular” Medicare
- Certification by attending physician and hospice medical director of terminal illness
.
Certification periods
- Initially eligible for two 90-day periods
- Re-certification every 60 days thereafter (Terminally ill certification by attending physician)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Levels of Hospice Care (4 of them)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

LO: Why is prognostication important? but why is it so difficult?

A
  • It allows for better informed decision making.
  • It helps determine risk and benefits for treatment decisions.
  • Patients and families want to know.
  • It is necessary for the Medicare Hospice Benefit
    .
    Why is it so difficult?
  • Lack of training
  • We tend to be overly optimistic
  • Lower amounts of quality research
  • Tools are often meant to determine prognosis for a single disease state
  • Predictions tools may lag newer therapies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

LO: How good are we in prognostication? Talk about the studies

A

Our Prognosis → Overestimate!
.
Study looked at 326 patients with cancer in 5 Chicago hospices
- 20% accuracy in predicting prognosis
- 63% overestimate, 17% underestimate
- Only 37% would give frank disclosure, even when patient requested survival estimate
- Closer the relationship – more likely to err (error)
- Prognostication – < 1 month, 1-6 months, or > 6 months
- Correct category - 58% accurate
- 85% accurate if prognosis 0-3 days (s/s is apparent when closer to death)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

LO: Advanced Cancer (general) / scales?

A
  • 30% of all deaths
  • Single biggest predictive factor in cancer is functional status!
  • Patients with solid tumors typically lose ~ 70% of their functional ability in the last 3 months of life.
  • Karnofsky Scale, ECOG, and Palliative Performance Scale most often used.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Advanced Cancer: Karnofsky Scale

A
  • Normal (100)
  • Dead (0)
  • 50 – considerable assistance with frequent medical care
    .
    NOTE- just know the general trend on the scale!
    100-80: able to preform/ no need for assistant
    80-40: unable to work, but able to care for self at home, may need assistant with various things
    Under 40: unable to care for self, need institution/ hospital help
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Advanced Cancer: Eastern Cooperative Oncology Group (ECOG)

A
  • Normal (0)
  • Dead (5)
  • 3 – limited self care / bed or chair > 50% of waking hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Advanced Cancer-KS and ECOG: important

A
  • Karnofsky < 40 or ECOG 3 ➔ median survival 3 months
  • How do you spend your time? How much time do you spend in a chair or lying down? If the response is >50% of the time, and is increasing, you can roughly estimate the prognosis at 3 months or less.
  • Survival time decreases further with increasing numbers of physical symptoms, especially dyspnea, if secondary to the cancer.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Advanced Cancer: Various situations and estimated survival time

A

1.) Malignant hypercalcemia: 8 weeks, except newly diagnosed breast cancer or myeloma
2.) Malignant pericardial effusion: 8 weeks
3.) Carcinomatous meningitis: 8-12 weeks
4.) Multiple brain metastases: 1-2 months without radiation; 3-6 months with radiation.
5.) Malignant ascites malignant pleural effusion or malignant bowel obstruction: < 6 months.
6.) A patient with metastatic solid cancer, acute leukemia or high-grade lymphoma, who will not be receiving systemic chemotherapy (for whatever reason) ➔ prognosis < 6 months. Exceptions are patients with metastatic breast or prostate cancer with good performance status, as these cancers may have an indolent course.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Principles of Symptom Management

A
  • Use frequent, standard assessment
  • Oral medications when possible, altering the route as needed
  • Assess for medication side effects; anticipate and treat as necessary
  • Discontinue medications no longer contributing to symptom control
  • Address possible reversible contributing causes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Importance of Deprescribing?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

N/V Assessment and Approach (general)

A
  • Self-report is gold standard for nausea, documentation of N/V
  • Other monitoring parameters: Food intake, Hydration status, Bowel movements
  • Documentation of relief from medication
  • Gastric + non-gastric trigger areas are involved in N/V
  • Five principal receptors mediate vomiting:
    —- Muscarinic M1
    —- Dopamine D2
    —- Histamine H1
    —- 5 hydroxytryptamine 5HT-3
    —- Neurokinin NK1
  • N/V are common at end of life: 40% of patients report N/V during the last 6 weeks of life
17
Q

N/V: Suspected Cause, Mechanism, Antiemetic (only know the 3 that are starred)

A
18
Q

Opioid-Induced Constipation: solution/ treatments?

A

First-line options: Stimulant laxatives (Senna, Bisacodyl), then can add Osmotic laxatives (Polyethylene glycol, Lactulose)… 2nd line stuff –> then Add additional agents if needed: Bisacodyl suppository, Magnesium, Evaluate for ileus Low or high impaction
.
What about docusate??
No significant between-group (docusate and sennosides OR placebo and sennosides)
differences in stool frequency, volume, or consistency; or difficulty of completeness of evacuation. NOTE: SHOULD NOT USE DOCUSATE AS A SINGLE AGENT! POINTLESS TO USE DOCUSATE IN OPIOID INDUCED CONSITPATION

19
Q

Malignant Bowel Obstruction: what is it? Tx?

A
  • Most common with abdominal cancers – ovarian, colon, pancreatic
  • Symptoms – n/v, abdominal pain (colicky or continuous) and distention, constipation, liquid stools
  • Treatment
    — Palliative surgery
    — Medical management – goal to eliminate need for NG tube and IV hydration (Opioids and antiemetics (i.e. haldol), Anticholinergics/antimuscarinics such as glycopyrrolate or hyoscyamine for colic pain, Octreotide, Corticosteroids
20
Q

Dyspnea: what is it? Tx (pharm/ nonpharm)?

A
  • Defined as a discomfort in breathing
  • Subjective sensation influenced by physical,
    psychological, social, and spiritual factors
  • Assessment based on subjective responses ONLY; no place for test
  • Pathophysiology: Physical respiratory impedance – pleural effusions, PE, increased secretions, pneumonia, COPD, weakness in
    respiratory muscles
  • Chemical causes – hypercapnia, hypoxia
  • Neuromechanical dissociation – mismatch between what the brain expects as respiration and signals it receives
    .
    TREATMENT
    1.) Non-pharmacologic: Re-positioning (avoid lying flat), cool room temps, relaxation exercises, acupuncture, minimal exertion
    2.) Pharmacologic
  • Oxygen therapy for documented hypoxia esp. COPD
  • Opioids – first-line treatment; MOA: Decrease chemoreceptor response to hypercapnia, increase peripheral vasodilatation with decrease in cardiac preload, decrease
    anxiety and subjective feeling of dyspnea (No optimal agent or dose although nebulized route not shown to be superior; consider opioid naïve vs. opioid-tolerant patient… Morphine most commonly used
  • Anxiolytics: Benzodiazepines (lorazepam) reserved for breakthrough or refractory dyspnea compounded by anxiety or when ADRs limit titration of opioids to efficacy
21
Q

Anorexia/Cachexia Treatment (nonpharm/ pharm)

A

Non-pharmacologic
- Reassurance that syndrome is part of the normal end-of-life process to decrease anxiety
- Dietary modifications – offer easy-to-swallow foods, limit dietary restrictions, frequent, small meals
- Artificial nutrition (enteral or parenteral) do not prolong life and increase costs and morbidity – SO WE DO NOT USE
.
Unlikely to improve survival but may improve QOL - Pharmacologic
1.) Megestrol acetate - May improve appetite (and increase weight) by increasing levels of orexigenic neurotransmitters in the hypothalamus or by interfering with production of cytokines by glucocorticoid activity
- no significant difference between low (≤800mg) and high (>800mg) daily doses)
- Dose related ADRs: Increased risk of VTEs, may suppress HPA axis
2.) Corticosteroids- Increase appetite and food intake; adjunct for pain, nausea; No known optimal dose- megestrol 800mg/day comparable to dexamethasone 3-4mg/day
- ADRs: cushingoid symptoms, hyperglycemia, gastric irritation
- Used short term!!!!
3.) Dronabinol
- FDA approved for anorexia in AIDS
- Significant improvements in appetite and food intake but no significant improvement in body weight
- Inferior to megestrol in advanced cancer
- ADRs: dose-related CNS effects

22
Q

Fatigue Management: Nonpharm/ Pharm

A

Non-pharmacologic: Education, exercise, acupuncture
.
Pharmacologic
- Psychostimulants (Methylphenidate, Modafanil)
- Corticosteroids (Dexamethasone)
- Megestrol
- Antidepressants (Bupropion, Paroxetine)

23
Q

Delirium (part 1): general/ symptoms/ causes

A
  • Most common neuropsychiatric complication in patients with advanced cancer
  • Disturbance in attention and awareness
  • Changes in cognition not explained by a pre-existing condition
    .
    Pathophysiology
  • Medication-induced – opioids, anticholinergics, benzodiazepines, corticosteroids
  • Infection
  • Urinary retention, fecal impaction, dehydration
  • Brain tumor/metastases
  • Metabolic disorders – hypercalcemia, hyponatremia, liver/renal failure
  • Other brain disorders – stroke, dementia
    .
    Symptoms:
  • Agitation
  • Restlessness
  • Altered perceptions
  • Difficulty forming thoughts and incoherent speech
  • Disorientation to time, place, person
  • Sleep disturbances and nightmares
  • Sundowning
  • Changes in consciousness level
24
Q

Delirium (part 2) - Treatment (nonpharm/ pharm)

A

1.) Non-pharmacologic: Provide calm environment, music, aromatherapy, spiritual
counselor, Identify any reversible causes (i.e. medications, constipation, urinary retention)
.
2.) Pharmacologic
- Antipsychotics considered 1st line
—- Most evidence with haloperidol and chlorpromazine (chlorpro has Anticholinergic Effects so use lowest most effective dose) given in low doses PRN; once total dose required to manage symptoms is identified, then given on scheduled bases and adjust accordingly… Quetiapine also used
—- Benzodiazepines useful for sedation when agitation is prominent feature and antipsychotics ineffective (use with caution as may worsen delirium)

25
Q

Anticholinergic Effects : peripheral vs central

A
26
Q

Dysphagia: what is it? what are the alternatives?

A
  • Can be associated with odynophagia and/or
    aspiration
  • Oral route fails in up to 70% of patients near the end of life (Occurs regularly in patients with advanced disease, especially in the setting of neurologic disease, ALS and other motor neuron diseases, brain metastases
  • Must proactively consider most appropriate route of non‐oral medication administration
  • Intravenous route not practical for home hospice patients (think of other non oral option like iv/ sq, transdermal, suppository, etc)
27
Q

Secretions (part 1): general/types/ talk about it

A
  • Respiratory secretions common in the last days of life… Most frequent with pulmonary malignancies and brain tumors
    —- ~76% of patients die within 48 hours of onset
    —- “Death rattle” disturbing for caregivers, painless to patient
    —- May often be corrected by re-positioning
  • Contributing factors: IV hydration or tube feedings, Diminished cough reflex or dysphagia, Prolonged dying phase
  • Type I - Predominantly salivary secretions
  • Type II - Predominantly bronchial secretions as part of normal mucous production and/or
    respiratory infections
28
Q

Secretions (part 2) – Treatment

A
  • If secretions are thick and patient is not close to death, consider optimizing hydration, nebulized NS and/or guaifenesin. If secretions thinner, can use gentle suctioning and anticholinergics. In patient near death, suctioning not recommended
    .
    Medication options: Anticholinergics
  • Atropine eye drops 1%
  • Scopolamine/Scopolamine patch
  • Hyoscyamine
  • Glycopyrrolate
29
Q

Last Hours of Life

A
  • Patients and families usually unaware of expected changes
  • IDT members should explain expected changes in cognition and physical function before they occur to alleviate distress
    —- Progressive unresponsiveness
    —- Purposeless movements and facial expressions
    —- Noisy breathing
    —- Unlikely periods of awareness just before death
30
Q

Don’t cry it’ll be ok

A

congrats on finishing your last exam ever in pharmacy school.